14 min
Laura O’Dell, CFA Discusses Genomics Understanding Edge
-
- Investing
Genomics, or the study of all the genes in a person’s body, has experienced tremendous growth over the past two decades, growth which is poised to continue. Our health care analyst Laura O’Dell joins us to discuss current players in the market, the challenges posed by the lack of universal regulations, and her view on the future of the industry.
This material is for informational purposes and is prepared by Diamond Hill Capital Management. The opinions expressed are as of the date of publication and are subject to change. These opinions are not intended to be a forecast of future events, a guarantee of future results, or investment advice. Reliance upon this information is at the sole discretion of the listener. Investing involves risk including the possible loss of principal.
Genomics, or the study of all the genes in a person’s body, has experienced tremendous growth over the past two decades, growth which is poised to continue. Our health care analyst Laura O’Dell joins us to discuss current players in the market, the challenges posed by the lack of universal regulations, and her view on the future of the industry.
This material is for informational purposes and is prepared by Diamond Hill Capital Management. The opinions expressed are as of the date of publication and are subject to change. These opinions are not intended to be a forecast of future events, a guarantee of future results, or investment advice. Reliance upon this information is at the sole discretion of the listener. Investing involves risk including the possible loss of principal.
14 min